Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Seprehvir |
Synonyms | |
Therapy Description |
Seprehvir (HSV1716) is a mutant herpes simplex virus type 1 that replicates specifically in cancer cells and induces anti-tumour immune response (Cancer Immunol Res 2016;4(1 Suppl):Abstract nr B033, PMID: 31570234). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Seprehvir | HSV1716 | Seprehvir (HSV1716) is a mutant herpes simplex virus type 1 that replicates specifically in cancer cells and induces anti-tumour immune response (Cancer Immunol Res 2016;4(1 Suppl):Abstract nr B033, PMID: 31570234). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|